The changes of renin, angiotensin and aldosterone with long term administration of olmesartan:COMPATIBLE extension study

The changes of renin, angiotensin and aldosterone with long term administration of olmesartan:COMPATIBLE extension study - COMPATIBLE extension RAS study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015323

Enrollment

100

Registered

2014-10-03

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Administration of Olmesartan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who were participants in the prior COMPATIBLE Study, and still takes Olmesartan at the same attended clinic.

Exclusion criteria

Exclusion criteria: The patient who do not take Olmesartan.

Design outcomes

Primary

Measure	Time frame
Aldosterone concentration	—

Secondary

Measure	Time frame
Renin Angiotensin I Angiotensin II Urinary albumin-to-creatinine ratio	—

Countries

Japan

Contacts

Public ContactHisao Mori

Kanagawa Association of Medical and Dental Practitioners Department of Clinical Research

hmori@gem.hi-ho.ne.jp045-313-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026